Free Trial
$100 Off Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 Now
Claim MarketBeat All Access Sale Promotion

SiriusPoint (SPNT) Competitors

SiriusPoint logo
$23.32 0.00 (-0.02%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$23.34 +0.02 (+0.08%)
As of 05/22/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SPNT vs. RYAN, JXN, OSCR, KNSL, and VOYA

Should you buy SiriusPoint stock or one of its competitors? MarketBeat compares SiriusPoint with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SiriusPoint include Ryan Specialty (RYAN), Jackson Financial (JXN), Oscar Health (OSCR), Kinsale Capital Group (KNSL), and Voya Financial (VOYA). These companies are all part of the "insurance" industry.

How does SiriusPoint compare to Ryan Specialty?

SiriusPoint (NYSE:SPNT) and Ryan Specialty (NYSE:RYAN) are both mid-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation, institutional ownership and media sentiment.

SiriusPoint presently has a consensus price target of $28.00, indicating a potential upside of 20.09%. Ryan Specialty has a consensus price target of $46.76, indicating a potential upside of 42.95%. Given Ryan Specialty's higher probable upside, analysts clearly believe Ryan Specialty is more favorable than SiriusPoint.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SiriusPoint
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Ryan Specialty
3 Sell rating(s)
6 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.42

In the previous week, Ryan Specialty had 1 more articles in the media than SiriusPoint. MarketBeat recorded 4 mentions for Ryan Specialty and 3 mentions for SiriusPoint. SiriusPoint's average media sentiment score of 0.18 beat Ryan Specialty's score of -0.32 indicating that SiriusPoint is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SiriusPoint
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Ryan Specialty
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

SiriusPoint has a beta of 0.66, suggesting that its stock price is 34% less volatile than the broader market. Comparatively, Ryan Specialty has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market.

SiriusPoint has a net margin of 15.38% compared to Ryan Specialty's net margin of 8.21%. Ryan Specialty's return on equity of 41.33% beat SiriusPoint's return on equity.

Company Net Margins Return on Equity Return on Assets
SiriusPoint15.38% 16.92% 2.88%
Ryan Specialty 8.21%41.33%4.80%

SiriusPoint has higher revenue and earnings than Ryan Specialty. SiriusPoint is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SiriusPoint$3.21B0.86$459.60M$4.025.80
Ryan Specialty$3.05B2.83$63.40M$0.7742.48

52.8% of SiriusPoint shares are owned by institutional investors. Comparatively, 84.8% of Ryan Specialty shares are owned by institutional investors. 12.2% of SiriusPoint shares are owned by company insiders. Comparatively, 52.0% of Ryan Specialty shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Ryan Specialty beats SiriusPoint on 11 of the 17 factors compared between the two stocks.

How does SiriusPoint compare to Jackson Financial?

Jackson Financial (NYSE:JXN) and SiriusPoint (NYSE:SPNT) are both mid-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

In the previous week, SiriusPoint had 2 more articles in the media than Jackson Financial. MarketBeat recorded 3 mentions for SiriusPoint and 1 mentions for Jackson Financial. SiriusPoint's average media sentiment score of 0.18 beat Jackson Financial's score of 0.00 indicating that SiriusPoint is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Jackson Financial
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
SiriusPoint
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

90.0% of Jackson Financial shares are owned by institutional investors. Comparatively, 52.8% of SiriusPoint shares are owned by institutional investors. 1.4% of Jackson Financial shares are owned by insiders. Comparatively, 12.2% of SiriusPoint shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

SiriusPoint has a net margin of 15.38% compared to Jackson Financial's net margin of 0.00%. Jackson Financial's return on equity of 17.21% beat SiriusPoint's return on equity.

Company Net Margins Return on Equity Return on Assets
Jackson FinancialN/A 17.21% 0.49%
SiriusPoint 15.38%16.92%2.88%

Jackson Financial currently has a consensus target price of $115.80, suggesting a potential upside of 8.11%. SiriusPoint has a consensus target price of $28.00, suggesting a potential upside of 20.09%. Given SiriusPoint's stronger consensus rating and higher probable upside, analysts plainly believe SiriusPoint is more favorable than Jackson Financial.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jackson Financial
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.43
SiriusPoint
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Jackson Financial has a beta of 1.39, indicating that its stock price is 39% more volatile than the broader market. Comparatively, SiriusPoint has a beta of 0.66, indicating that its stock price is 34% less volatile than the broader market.

SiriusPoint has lower revenue, but higher earnings than Jackson Financial. Jackson Financial is trading at a lower price-to-earnings ratio than SiriusPoint, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jackson Financial$6.68B1.12$27M-$6.11N/A
SiriusPoint$3.21B0.86$459.60M$4.025.80

Summary

SiriusPoint beats Jackson Financial on 11 of the 17 factors compared between the two stocks.

How does SiriusPoint compare to Oscar Health?

SiriusPoint (NYSE:SPNT) and Oscar Health (NYSE:OSCR) are both mid-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, media sentiment, profitability and earnings.

SiriusPoint currently has a consensus price target of $28.00, suggesting a potential upside of 20.09%. Oscar Health has a consensus price target of $18.22, suggesting a potential downside of 19.61%. Given SiriusPoint's stronger consensus rating and higher possible upside, equities research analysts plainly believe SiriusPoint is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SiriusPoint
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Oscar Health
2 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.17

In the previous week, Oscar Health had 7 more articles in the media than SiriusPoint. MarketBeat recorded 10 mentions for Oscar Health and 3 mentions for SiriusPoint. Oscar Health's average media sentiment score of 0.75 beat SiriusPoint's score of 0.18 indicating that Oscar Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SiriusPoint
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Oscar Health
5 Very Positive mention(s)
4 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SiriusPoint has a net margin of 15.38% compared to Oscar Health's net margin of -0.30%. SiriusPoint's return on equity of 16.92% beat Oscar Health's return on equity.

Company Net Margins Return on Equity Return on Assets
SiriusPoint15.38% 16.92% 2.88%
Oscar Health -0.30%-3.26%-0.57%

52.8% of SiriusPoint shares are held by institutional investors. Comparatively, 75.7% of Oscar Health shares are held by institutional investors. 12.2% of SiriusPoint shares are held by insiders. Comparatively, 24.4% of Oscar Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

SiriusPoint has higher earnings, but lower revenue than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than SiriusPoint, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SiriusPoint$3.21B0.86$459.60M$4.025.80
Oscar Health$11.70B0.58-$443.15M-$0.59N/A

SiriusPoint has a beta of 0.66, suggesting that its share price is 34% less volatile than the broader market. Comparatively, Oscar Health has a beta of 2.34, suggesting that its share price is 134% more volatile than the broader market.

Summary

SiriusPoint beats Oscar Health on 10 of the 17 factors compared between the two stocks.

How does SiriusPoint compare to Kinsale Capital Group?

SiriusPoint (NYSE:SPNT) and Kinsale Capital Group (NYSE:KNSL) are both mid-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

SiriusPoint has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market. Comparatively, Kinsale Capital Group has a beta of 0.95, indicating that its share price is 5% less volatile than the broader market.

Kinsale Capital Group has lower revenue, but higher earnings than SiriusPoint. SiriusPoint is trading at a lower price-to-earnings ratio than Kinsale Capital Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SiriusPoint$3.21B0.86$459.60M$4.025.80
Kinsale Capital Group$1.87B3.82$503.61M$22.7213.67

In the previous week, Kinsale Capital Group had 4 more articles in the media than SiriusPoint. MarketBeat recorded 7 mentions for Kinsale Capital Group and 3 mentions for SiriusPoint. Kinsale Capital Group's average media sentiment score of 0.80 beat SiriusPoint's score of 0.18 indicating that Kinsale Capital Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SiriusPoint
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Kinsale Capital Group
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

SiriusPoint presently has a consensus target price of $28.00, indicating a potential upside of 20.09%. Kinsale Capital Group has a consensus target price of $390.18, indicating a potential upside of 25.63%. Given Kinsale Capital Group's higher probable upside, analysts plainly believe Kinsale Capital Group is more favorable than SiriusPoint.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SiriusPoint
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Kinsale Capital Group
2 Sell rating(s)
8 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00

Kinsale Capital Group has a net margin of 27.48% compared to SiriusPoint's net margin of 15.38%. Kinsale Capital Group's return on equity of 25.82% beat SiriusPoint's return on equity.

Company Net Margins Return on Equity Return on Assets
SiriusPoint15.38% 16.92% 2.88%
Kinsale Capital Group 27.48%25.82%8.20%

52.8% of SiriusPoint shares are held by institutional investors. Comparatively, 85.4% of Kinsale Capital Group shares are held by institutional investors. 12.2% of SiriusPoint shares are held by insiders. Comparatively, 5.6% of Kinsale Capital Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Kinsale Capital Group beats SiriusPoint on 12 of the 16 factors compared between the two stocks.

How does SiriusPoint compare to Voya Financial?

SiriusPoint (NYSE:SPNT) and Voya Financial (NYSE:VOYA) are both mid-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.

SiriusPoint has a net margin of 15.38% compared to Voya Financial's net margin of 8.24%. SiriusPoint's return on equity of 16.92% beat Voya Financial's return on equity.

Company Net Margins Return on Equity Return on Assets
SiriusPoint15.38% 16.92% 2.88%
Voya Financial 8.24%13.84%0.52%

52.8% of SiriusPoint shares are owned by institutional investors. Comparatively, 96.1% of Voya Financial shares are owned by institutional investors. 12.2% of SiriusPoint shares are owned by company insiders. Comparatively, 1.6% of Voya Financial shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Voya Financial has higher revenue and earnings than SiriusPoint. SiriusPoint is trading at a lower price-to-earnings ratio than Voya Financial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SiriusPoint$3.21B0.86$459.60M$4.025.80
Voya Financial$8.19B0.91$654M$6.6212.44

SiriusPoint has a beta of 0.66, meaning that its share price is 34% less volatile than the broader market. Comparatively, Voya Financial has a beta of 0.94, meaning that its share price is 6% less volatile than the broader market.

In the previous week, Voya Financial had 5 more articles in the media than SiriusPoint. MarketBeat recorded 8 mentions for Voya Financial and 3 mentions for SiriusPoint. Voya Financial's average media sentiment score of 0.60 beat SiriusPoint's score of 0.18 indicating that Voya Financial is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SiriusPoint
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Voya Financial
1 Very Positive mention(s)
4 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

SiriusPoint currently has a consensus price target of $28.00, indicating a potential upside of 20.09%. Voya Financial has a consensus price target of $88.40, indicating a potential upside of 7.33%. Given SiriusPoint's higher probable upside, research analysts clearly believe SiriusPoint is more favorable than Voya Financial.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SiriusPoint
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Voya Financial
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64

Summary

Voya Financial beats SiriusPoint on 11 of the 16 factors compared between the two stocks.

Get SiriusPoint News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPNT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SPNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPNT vs. The Competition

MetricSiriusPointINS IndustryFinance SectorNYSE Exchange
Market Cap$2.74B$21.09B$13.60B$23.20B
Dividend YieldN/A3.00%5.84%4.10%
P/E Ratio5.809.1724.8327.82
Price / Sales0.861.58153.6224.50
Price / Cash9.0111.1020.1525.12
Price / Book1.192.182.154.74
Net Income$459.60M$1.86B$1.13B$1.07B
7 Day Performance-2.15%-1.38%0.61%1.45%
1 Month Performance-1.93%0.36%-0.07%1.58%
1 Year Performance21.63%3.57%12.01%28.44%

SiriusPoint Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPNT
SiriusPoint
3.7281 of 5 stars
$23.32
0.0%
$28.00
+20.1%
+21.6%$2.74B$3.21B5.801,099
RYAN
Ryan Specialty
4.5925 of 5 stars
$33.66
0.0%
$47.82
+42.1%
-52.4%$8.90B$3.05B43.716,110
JXN
Jackson Financial
1.4114 of 5 stars
$108.13
-2.5%
$115.80
+7.1%
+32.4%$7.74B$6.68BN/A3,890
OSCR
Oscar Health
3.4973 of 5 stars
$24.53
-3.0%
$18.22
-25.7%
+60.3%$7.63B$11.70BN/A2,305
KNSL
Kinsale Capital Group
4.4113 of 5 stars
$314.72
-3.1%
$392.00
+24.6%
-33.0%$7.49B$1.87B13.85470

Related Companies and Tools


This page (NYSE:SPNT) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners